The nib Holdings Ltd (ASX: NHF) share price is in focus today after the health insurance provider reported a 6.2% lift in group revenue to $3.8 billion and a 9.1% rise in underlying operating profit to $260.9 million for FY26.
Image source: Getty Images
What did nib report?
- Group underlying operating profit (UOP) up 9.1% to $260.9 million
- Group revenue rose 6.2% to $3.8 billion
- Net profit after tax of $186.9 million, down 5.9%
- Final dividend of 21.0 cents per share, including a 5c special dividend
- Australian resident policyholder growth of 1.9%
- Operating expense ratio improved to 16.6%
What else do investors need to know?
nib's Australian residents health insurance business saw record sales, though its UOP fell 9.6% to $187.9 million due to higher risk equalisation and rebate impacts. The International segment performed strongly with UOP up 15.1% and policyholder growth of 4.4%. New Zealand operations delivered a turnaround, moving from a loss in FY25 to $27.5 million in UOP, thanks to pricing and claims management.
During FY26, nib also concluded the sale of its nib Travel business, sharpening its strategic focus. The completion, expected in FY27, will provide around $97 million in net cash, supporting the recently announced special dividend and future capital management.
What did nib management say?
Managing Director and Chief Executive Officer Ed Close said:
nib Group's FY26 result reflects a year of disciplined growth and continued progress in helping our customers access and navigate healthcare with confidence. Group revenue increased 6.2% to $3.8 billion and underlying operating profit (UOP) increased 9.1% to $260.9 million, supported by growth across our Australian residents business, pleasing International performance, a strong recovery in New Zealand, Health Services shifting into profitability and continued productivity improvements. Net profit after tax was $186.9 million, ahead of expectations…Looking ahead, we will continue focusing on customer value, affordability, access to care and sustainable growth. We remain committed to strengthening provider partnerships, expanding health management and care navigation services and leveraging technology, data and AI to make healthcare simpler, more accessible and more personalised for our customers.
What's next for nib?
For FY27, nib is guiding for group UOP of $265–$285 million (excluding nib Travel), with ongoing productivity and digital improvements expected to further reduce costs. The group plans to drive sustainable policyholder growth in Australia and expand its role in health management and care navigation.
Completion of the nib Travel sale will enhance balance sheet flexibility, giving nib more options for capital management. Key focus areas include leveraging technology—such as AI-driven claims management—and maintaining strong customer advocacy, while seeking steady growth across its core insurance and health services businesses.
nib share price snapshot
Over the past 12 months, nib shares have declined 7%, trailing the All Ordinaries Index (ASX: XAO), which is flat over the same period.
